Beijing Tiantan Biological Products Corp. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -34.34% vs 27.46% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -51.52% vs 45.03% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,118.20",
          "val2": "1,703.00",
          "chgp": "-34.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "196.20",
          "val2": "584.90",
          "chgp": "-66.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "179.10",
          "val2": "369.40",
          "chgp": "-51.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "175.50%",
          "val2": "276.40%",
          "chgp": "-10.09%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 2.22% vs 17.02% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -29.47% vs 39.93% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,138.60",
          "val2": "6,005.30",
          "chgp": "2.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,219.70",
          "val2": "2,825.70",
          "chgp": "-21.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.00",
          "val2": "7.90",
          "chgp": "26.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.50",
          "val2": "-21.10",
          "chgp": "145.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,489.90",
          "val2": "2,112.30",
          "chgp": "-29.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "287.70%",
          "val2": "410.80%",
          "chgp": "-12.31%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,118.20

1,703.00

-34.34%

Operating Profit (PBDIT) excl Other Income

196.20

584.90

-66.46%

Interest

1.80

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

179.10

369.40

-51.52%

Operating Profit Margin (Excl OI)

175.50%

276.40%

-10.09%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -34.34% vs 27.46% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -51.52% vs 45.03% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

6,138.60

6,005.30

2.22%

Operating Profit (PBDIT) excl Other Income

2,219.70

2,825.70

-21.45%

Interest

10.00

7.90

26.58%

Exceptional Items

9.50

-21.10

145.02%

Consolidate Net Profit

1,489.90

2,112.30

-29.47%

Operating Profit Margin (Excl OI)

287.70%

410.80%

-12.31%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 2.22% vs 17.02% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -29.47% vs 39.93% in Dec 2024

All Annual Results